The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–233 of 233
de Weijer, A. D., Neggers, S. F. W., Diederen, K. M. J., Mandl, R. C. W., Kahn, R. S., Pol, H. E. H., & Sommer, I. E. (2011) · Human Brain Mapping · doi:10.1002/hbm.21463 · Cited by 87
Self-citationIyegbe, C. O., Campbell, D., Butler, A. W., Ajnakina, O., & Sham, P. C. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0823-2 · Cited by 85
New second-generation long-acting injectable antipsychotics for the treatment of schizophrenia
Citrome, L. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811984 · Cited by 82
de Candia, T. R., Lee, S., Yang, J., Browning, B. L., Gejman, P. V., Levinson, D. F., Mowry, B. J., Hewitt, J. K., Goddard, M. E., O’Donovan, M. C., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.07.007 · Cited by 75
Self-citationWhat can we learn about schizophrenia from studying the human model, drug‐induced psychosis?
Murray, R. M., Paparelli, A., Morrison, P. D., Marconi, A., & Forti, M. D. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32177 · Cited by 73
Self-citationBharadwaj, R. A., Jiang, Y., Mao, W., Jakovcevski, M., Dincer, A., Krueger, W. H., Garbett, K. A., Whittle, C., Tushir, J. S., Liu, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1252-13.2013 · Cited by 71
Kunitoh, N. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12071 · Cited by 70
Ibrahim, N., Michail, M., & Callaghan, P. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0243-6 · Cited by 69
Schrank, B., Bird, V., Tylee, A. T., Coggins, T., Rashid, T., & Slade, M. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.05.011 · Cited by 66
Magnetic Resonance Imaging Predictors of Treatment Response in First-Episode Schizophrenia
Szeszko, P. R., Narr, K. L., Phillips, O. R., McCormack, J., Sevy, S. M., Gunduz‐Bruce, H., Kane, J. M., Bilder, R. M., & Robinson, D. G. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq126 · Cited by 66
Self-citationMitchell, A., Jiang, Y., Peter, C. J., & Akbarian, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.020 · Cited by 65
Jaskiw, G. E., Karoum, F., & Weinberger, D. R. (1990) · Brain Research · doi:10.1016/0006-8993(90)90149-6 · Cited by 65
Self-citationSouza, J. S., Kayo, M., Tassell, I., Martins, C. B., & Elkis, H. (2012) · CNS Spectrums · doi:10.1017/s1092852912000806 · Cited by 64
Seidman, L. J., Hellemann, G., Nuechterlein, K. H., Greenwood, T. A., BRAFF, D. L., Cadenhead, K. S., Calkins, M. E., Freedman, R., Gur, R. E., Gur, R. C., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.027 · Cited by 63
Hjorth, P., Davidsen, A. S., Kilian, R., & Skrubbeltrang, C. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12245 · Cited by 60
Emerging drugs for schizophrenia: an update
Köster, L.-S., Carbon, M., & Correll, C. U. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.958148 · Cited by 55
Self-citationThe course and correlates of everyday functioning in schizophrenia
Reichenberg, A., Feo, C., Prestía, D., Bowie, C. R., Patterson, T. L., & Harvey, P. D. (2014) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2014.03.001 · Cited by 53
Review: The biological basis of antipsychotic response in schizophrenia
Stone, J. M., Raffin, M., Morrison, P., & McGuire, P. K. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106959 · Cited by 51
Lopez, L. V., & Kane, J. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.002 · Cited by 51
Self-citationEnuresis as a premorbid developmental marker of schizophrenia
Hyde, T. M., Deep‐Soboslay, A., Iglesias, B., Callicott, J. H., Gold, J. M., Meyer‐Lindenberg, A., Honea, R. A., Bigelow, L. B., Egan, M. F., Emsellem, E. M., et al. (2008) · Brain · doi:10.1093/brain/awn167 · Cited by 47
Self-citationHippocampal Function in Healthy Carriers of theCLUAlzheimer's Disease Risk Variant
Erk, S., Meyer‐Lindenberg, A., von Boberfeld, C. O., Esslinger, C., Schnell, K., Kirsch, P., Mattheisen, M., Mühleisen, T. W., Cichon, S., Witt, S. H., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4960-11.2011 · Cited by 46
Self-citationEsslinger, C., Braun, U., Schirmbeck, F. N., Santos, A., Meyer‐Lindenberg, A., Zink, M., & Kirsch, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058536 · Cited by 42
Self-citationPredictors and markers of clozapine response
Chung, C., & Remington, G. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2174-x · Cited by 41
Acute and Long-Term Adverse Effects of Antipsychotics
Correll, C. U. (2007) · CNS Spectrums · doi:10.1017/s1092852900015959 · Cited by 33
Self-citationMichalopoulou, P. G., Lewis, S. W., Wykes, T., Jaeger, J., & Kapur, S. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.03.012 · Cited by 30
The rationale for early intervention in schizophrenia and related disorders
Nordentoft, M., Jeppesen, P., Petersen, L., Bertelsen, M., & Thorup, A. A. E. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00123.x · Cited by 26
Weinberger, D. R. (2010) · Wiley eBooks · doi:10.1002/9781444327298 · Cited by 26
Self-citationThe interrelation of needs and quality of life in first-episode schizophrenia
Landolt, K., Wulf Rössler, A., Burns, T., Ajdacic‐Gross, V., Galderisi, S., Libiger, J., Naber, D., Derks, E. M., Kahn, R. S., & Fleischhacker, W. W. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0275-6 · Cited by 19
Self-citationJääskeläinen, E., Miettunen, J., Veijola, J. M., McGrath, J. J., Murray, G. K., Jones, P. B., & Isohanni, M. K. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.024 · Cited by 18
Programmes pour premiers épisodes psychotiques : une revue systématique de la littérature
Skalli, L., & Nicole, L. (2010) · L Encéphale · doi:10.1016/j.encep.2010.08.004 · Cited by 15
Assumptions and Properties of Limiting Pathway Models for Analysis of Epistasis in Complex Traits
Stringer, S., Derks, E. M., Kahn, R. S., Hill, W. G., & Wray, N. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068913 · Cited by 12
Self-citationMoskvina, V., Craddock, N. J., Müller‐Myhsok, B., Kam-Thong, T., Green, E., Holmans, P., Owen, M. J., & O’Donovan, M. C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.034 · Cited by 11
Self-citationCardno, A. G., & Gottesman, I. I. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(200021)97:1<12::aid-ajmg3>3.0.co;2-u
Cited by
Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., Jones, E. J. H., Jones, R. M., Pickles, A., State, M. W., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0138-4 · Cited by 1,859
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Correll, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225643 · Cited by 911
Self-citationCorrell, C. U., Galling, B., Pawar, A., Krivko, A., Bonetto, C., Ruggeri, M., Craig, T. J., Nordentoft, M., Srihari, V. H., Guloksuz, S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0623 · Cited by 826
Self-citationMarx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
Metadata
- Authors
- Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O'Donovan, M., Correll, C. U., Kane, J. M., van Os, J., & Insel, T. R.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-11-12
- Volume
- 1
- Issue
- 1
- Pages
- 15067-15067
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4211025465
- Cited by
- 1,124
- References
- 233
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.